Day 1 – 17 September |
Event-Based Access Control – Game Changer for Autonomous Security and Transparent Data Sharing | Amit Gautam, Abluva |
Rare Disease – Overcoming Barriers to Controlled Access SharingHelen Spotswood, Roche & Karolina Stępniak, AstraZeneca | Optimising the Utility of Anonymised Data: A Clinical Case Study | Lisa Pilgram, University of Ottawa |
Diversity in Clinical Trial Data : A New Horizon for Data Sharing with Truthful StatisticsLuk Arbuckle, Privacy Analytics & Stephen Bamford, Johnson & Johnson | Day 2 – 18 September |
Disclosure Without Exposure – Upstream Strategies for Enabling AI to Effectively and Efficiently Protect Clinical Data | Honz Slipka, Certara |
Harnessing the Power of Artificial Intelligence (AI) in Accelerating Production of Clinical Documentation: A Case Study with Plain Language Summaries (PLS) | Kathi Künnemann, Staburo |
De-Identification of Medical Data for AI Training, Speeding Up Clinical Trials, and Enabling Healthcare Research | Patricia Thaine, Private AI |
Leveraging Agentic AI Networks to Automate Transparency Activities | Woo Song, Xogene |
Day 3 – 19 September |
Privacy Methodology Implementation: Sharing Experience from the Field | Véronique Poinsot, Sanofi |
True Re-Identification Risk Threshold – Aggregated-Level Clinical Information Impact on Anonymisation Methods Applied to Individual Patient-Level Data (IPLD) | Agnieszka Głowińska & Łukasz Szyszka, AstraZeneca |
Writing Better CSRs to Facilitate Anonymisation for Clinical Data Publication | Cathal Gallagher & Laura Dodd, Instem |
A Data Transparency Odyssey - A Decade of Data Sharing | Alex Hughes, Roche & Brent Caldwell, Novartis |
Data Transparency Autumn Event Sponsors |
---|
|
Sponsor Flyers |
---|
|
Sponsorship |
---|
Hosting the Data Transparency Event digitally means that no matter where you are in the world you can participate. It provides the industry with a broader opportunity to share knowledge on a global scale, connecting through the virtual event platform. The sponsor options offer a range of benefits with ample company exposure. See the prospectusfor more detail. Image RemovedImage Added |